Related Experiment Videos
Response to correspondence from Gripp et al.-"clinical and molecular diagnosis should be consistent"
American Journal of Medical Genetics. Part A
|September 2, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
De novo triplication at 1p36.23p36.22 further refines the dosage sensitive region of overlap in Setleis syndrome (focal facial dermal dysplasia type III).
American journal of medical genetics. Part A·2023
Development of a comprehensive approach to adult hereditary cancer testing in Ontario.
Journal of medical genetics·2022
The Clinical Landscape of NRAS- mutated Juvenile Myelomonocytic Leukemia-like Myeloproliferation Includes Children With Costello Syndrome.
Journal of pediatric hematology/oncology·2022
Severe Headbanging Responsive to Levodopa in a Child With FOXP1 Syndrome.
American journal of medical genetics. Part A·2026
The Importance of Familial Co-segregation in the Classification of a Novel PKD1 Variant Associated With Autosomal Dominant Polycystic Kidney Disease.
American journal of medical genetics. Part A·2026
Exome Sequencing Uncovers Phenotypic and Genotypic Heterogeneity in 196 Indian Families Evaluated for Autoinflammatory Disorders.
American journal of medical genetics. Part A·2026
The Evaluation of Molecular Genetics and Clinical Manifestations in Patients With LZTR1-Associated Noonan Syndrome: A Retrospective Chart Review and Review of Literature.
American journal of medical genetics. Part A·2026
Expanding the Genotypic and Phenotypic Spectrum of Vissers-Bodmer Syndrome.
American journal of medical genetics. Part A·2026
Clinical and Functional Characterization of Gain-of-Function ABL1 Variants Expands the Phenotypic Spectrum of CHDSKM.
American journal of medical genetics. Part A·2026
Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.
Journal of medicinal chemistry·2026
Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.
Journal of medicinal chemistry·2026
Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.
Frontiers in aging·2026